Goodman R R, Snyder S H
Proc Natl Acad Sci U S A. 1982 Sep;79(18):5703-7. doi: 10.1073/pnas.79.18.5703.
Kappa opiate drugs differ from other opiates in their unique sedative actions and lack of cross-tolerance. We have visualized kappa opiate receptors by in vitro autoradiography using the kappa drugs [3H]ethylketazocine ([3H]EKC) and [3H]bremazocine. Though these ligands also label mu and delta opiate receptors, their binding is rendered kappa specific by coincubation with morphine and [D-Ala2, D-Leu5]enkephalin (DADL-Enk) to displace mu and delta interactions, respectively. Labeling patterns with [3H]EKC and [3H]bremazocine are the same and differ markedly from localizations of mu and delta opiate receptors visualized with [3H]dihydromorphine and [3H]DADL-Enk, respectively. The highest density and most selective localization of putative kappa receptors occurs in layers V and VI of the cerebral cortex. In these layers cells are localized which project to the thalamus regulating sensory input to the cortex. Receptors in these layers could account for the unique sedative and possibly analgesic effects of kappa opiates.
κ阿片类药物在其独特的镇静作用和缺乏交叉耐受性方面与其他阿片类药物不同。我们通过使用κ药物[3H]乙基酮佐辛([3H]EKC)和[3H]布瑞马佐辛的体外放射自显影术对κ阿片受体进行了可视化。尽管这些配体也标记μ和δ阿片受体,但通过分别与吗啡和[D - Ala2,D - Leu5]脑啡肽(DADL - Enk)共同孵育以取代μ和δ相互作用,它们的结合具有κ特异性。[3H]EKC和[3H]布瑞马佐辛的标记模式相同,并且与分别用[3H]二氢吗啡和[3H]DADL - Enk可视化的μ和δ阿片受体的定位明显不同。假定的κ受体的最高密度和最具选择性的定位出现在大脑皮层的V层和VI层。在这些层中定位着投射到丘脑以调节对皮层感觉输入的细胞。这些层中的受体可能解释了κ阿片类药物独特的镇静作用以及可能的镇痛作用。